Aaron W James

Aaron W James

Auto-generated profile, based on publicly available information

Aaron W James

Department of Pathology, Johns Hopkins University , Baltimore , M D , USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2023 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
PDF file
MGMario A Gomez-Salazar
Mario A Gomez-Salazar
YWYiyun Wang
Yiyun Wang
NTNeelima Thottappillil
Neelima Thottappillil
RHReef W Hardy
Reef W Hardy
MAManon Alexandre
Manon Alexandre
BPBruno Peault
Bruno Peault
Innate mesenchymal stem cells exhibiting multilineage differentiation and tissue (re)generative—or pathogenic—properties reside in perivascular niches. Subsets of these progenitors are committed to either osteo-, adipo-, or fibrogenesis, suggesting the existence of a developmental organization in blood vessel walls. We evaluated herein the activity of aldehyde dehydrogenase, a family of enzymes catalyzing the oxidation of aldehydes into carboxylic acids and a reported biomarker of normal and malignant stem cells, within human adipose tissue perivascular areas. A progression of ALDHLow to ALDHHigh CD34+ cells was identified in the tunica adventitia. Mesenchymal stem cell potential was confined to ALDHHigh cells, as assessed by proliferation and multilineage differentiation in vitro of cells sorted by flow cytometry with a fluorescent ALDH substrate. RNA sequencing confirmed and validated that ALDHHigh cells have a progenitor cell phenotype and provided evidence that the main isoform in this fraction is ALDH1A1, which was confirmed by immunohistochemistry. This demonstrates that ALDH activity, which marks hematopoietic progenitors and stem cells in diverse malignant tumors, also typifies native, blood vessel resident mesenchymal stem cells.

15 June 2023 in Stem Cells
Verified
Journal Article
Open access
PDF file
NTNeelima Thottappillil
Neelima Thottappillil
MGMario A Gomez-Salazar
Mario A Gomez-Salazar
MXMingxin Xu
Mingxin Xu
QQQizhi Qin
Qizhi Qin
XXXin Xing
Xin Xing
AJAaron W James
Aaron W James
Numerous intrinsic factors regulate mesenchymal progenitor commitment to a specific cell fate, such as osteogenic or adipogenic lineages. Identification and modulation of novel intrinsic regulatory factors represent an opportunity to harness the regenerative potential of mesenchymal progenitors. In the present study, the transcription factor (TF) ZIC1 was identified to be differentially expressed among adipose- compared to skeletal-derived mesenchymal progenitor cells. We observed that ZIC1 overexpression in human mesenchymal progenitors promotes osteogenesis and prevents adipogenesis. ZIC1 knockdown demonstrated the converse effects on cell differentiation. ZIC1 misexpression was associated with altered Hedgehog signaling, and the Hedgehog antagonist cyclopamine reversed the osteo/adipogenic differentiation alterations associated with ZIC1 overexpression. Finally, human mesenchymal progenitor cells with or without ZIC1 overexpression were implanted in an ossicle assay in NOD-SCID gamma mice. ZIC1 overexpression led to significantly increased ossicle formation in comparison to the control, as assessed by radiographic and histologic measures. Together, these data suggest that ZIC1 represents a transcription factor at the center of osteo/adipogenic cell fate determinations – findings that have relevance in the fields of stem cell biology and therapeutic regenerative medicine.